Integra Lifesciences completes enrollment in DuraSorb monofilament mesh IDE study
Integra LifeSciences [WtwhTicker symbol="IART"](Nasdaq: IART)[/WtwhTicker] announced that it completed enrollment ints U.S. DuraSorb trial.
Source: massdevice.com
Stay updated with breaking news from Yoons Chun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Integra LifeSciences [WtwhTicker symbol="IART"](Nasdaq: IART)[/WtwhTicker] announced that it completed enrollment ints U.S. DuraSorb trial.
Achieves Significant Milestone on Pathway to PMA Approval for Two-Stage Breast Reconstruction...